Back

Targeting RNA to reverse pathological cardiac hypertrophy.

26 August 2022 (16:30 - 16:45)
Organised by:
Congress Presentation Part of: Emerging role of RNAs as treatment targets in cardiovascular disease Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Thomas Thum

Institute for Molecular and Translational Therapeutic Strategies (IMTTS), Hannover (Germany)

3 More presentations in this session

Presentation thumbnail
Targeting RNA to facilitate cardiac remodelling and to treat heart failure.
Mrs P. da Costa Martins (Maastricht, NL)
Slides Video
Presentation thumbnail
Targeting RNA for treatment of dyslipidaemias.
Professor S. Tsimikas (La Jolla, US)
Slides Video
Presentation thumbnail
Emerging role of RNAs as treatment targets in cardiovascular disease – discussion.

Access the full session

Session thumbnail
Emerging role of RNAs as treatment targets in cardiovascular disease
Video

The Event

Event poster

ESC Congress 2022

26 August 2022 16:30 CET
You may be interested in
thumbnail
Congress Presentation
Targeting long non-coding RNAs in cardiac hypertrophy.
22 May 2022
thumbnail
Congress Presentation
Strategies to deliver therapeutic RNAs in cardiovascular diseases
2 September 2024
thumbnail
Congress Session
Epigenetic regulators and tools
2 September 2024
thumbnail
Congress Presentation
Serum exosomal long non-coding RNA H19 as a theragnostic target for atrial fibrillation
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources